TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34848169

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg every 4 weeks (Rq4)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 4 weeks (2q4)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks after 3 monthly doses (2q8)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: Overall analysis
Number of subjects: 1815
Study: 35325334

Group type: EXPERIMENTAL
Intervention: Victims of bullying
Number of subjects: 5208

Group type: COMPARATOR
Intervention: Control group (non-victims of bullying)
Number of subjects: 5208

Group type: EXPERIMENTAL
Intervention: Female students
Number of subjects: 5208
Study: 33677463

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 25
Study: 32737183

Group type: EXPERIMENTAL
Intervention: Muscimol infusion into the periaqueductal gray (PAG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion into the PAG
Number of subjects: 0
Study: 34928310

Group type: EXPERIMENTAL
Intervention: Regional anesthesia (spinal, epidural, or both techniques combined with no sedation; n=476)
Number of subjects: 950

Group type: COMPARATOR
Intervention: General anesthesia (intravenous, inhalational, or combined anesthetic agents; n=474)
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 950

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 950
Study: 33198837

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS) training including a 30-minute lecture and hands-on training
Number of subjects: 60

Group type: COMPARATOR
Intervention: No POCUS training (Control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS) training
Number of subjects: 60
Study: 32241367

Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 3324

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 3324
Study: 34262260

Group type: EXPERIMENTAL
Intervention: TPN171H (5-30 mg dose range)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: TPN171H under fed condition
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: TPN171H (multiple dosing)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: TPN171H
Number of subjects: 63
Study: 33156923

Group type: EXPERIMENTAL
Intervention: Emicizumab
Number of subjects: 66

Group type: COMPARATOR
Intervention: ELOCTATE
Number of subjects: 66
Study: 37045496

Group type: EXPERIMENTAL
Intervention: Dissolve DCB
Number of subjects: 260

Group type: COMPARATOR
Intervention: SeQuent Please DCB
Number of subjects: 260
Study: 32851466

Group type: EXPERIMENTAL
Intervention: Remote-controlled camera holder (RCH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Human camera assistant (HCA)
Number of subjects: 40
Study: 35997620

Group type: EXPERIMENTAL
Intervention: mDOT (modified directly observed therapy)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall HCV treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Baseline alcohol consumption
Number of subjects: 150

Group type: COMPARATOR
Intervention: Overall treatment groups
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall days of drinking
Number of subjects: 150

Group type: COMPARATOR
Intervention: Drinking to intoxication
Number of subjects: 150
Study: 33564828

Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (20 g/d soy protein isolate, providing 41 mg/d total isoflavones and 23 mg/d genistein)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Soy protein supplementation
Number of subjects: 93

Group type: COMPARATOR
Intervention: Casein-based placebo
Number of subjects: 93
Study: 32824308

Group type: EXPERIMENTAL
Intervention: Chinese Healthy Eating Index (CHEI) assessment
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: CHEI scores among ethnic minority groups and women younger than 30 years
Number of subjects: 404
Study: 35190534

Group type: EXPERIMENTAL
Intervention: Biannual mass distribution of azithromycin
Number of subjects: 3814
Study: 32907814

Group type: EXPERIMENTAL
Intervention: Risk-reducing early salpingectomy with delayed oophorectomy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Risk-reducing salpingo-oophorectomy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Controls (no surgery)
Number of subjects: 1000
Study: 33196579

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Single antiplatelet therapy (not explicitly mentioned but implied as control)
Number of subjects: 3
Study: 33228807

Group type: EXPERIMENTAL
Intervention: UVR-sensor wearable device (Shade) with notifications and an informational brochure about sun protection behaviors
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group receiving the device without notifications or summary UVR exposure data
Number of subjects: 368
Study: 35417027

Group type: EXPERIMENTAL
Intervention: Gold Standard Program (GSP-A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 70
Study: 34783672

Group type: EXPERIMENTAL
Intervention: Granular privacy control
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Perceived risk
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Trust in the system
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Perceived benefits
Number of subjects: 270
Study: 32532221

Group type: EXPERIMENTAL
Intervention: Perturbation-based balance training (PBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control intervention (general balance exercises)
Number of subjects: 34
Study: 35442784

Group type: EXPERIMENTAL
Intervention: Intervention arm 'More' (text messages, digital health care workers, community health fair)
Number of subjects: 4342

Group type: EXPERIMENTAL
Intervention: Intervention arm 'Most' (text messages, digital health care workers, community health fair)
Number of subjects: 4342

Group type: EXPERIMENTAL
Intervention: Intervention arm 'Least' (text-only)
Number of subjects: 4342

Group type: COMPARATOR
Intervention: Preintervention period
Number of subjects: 4342
Study: 34390226

Group type: EXPERIMENTAL
Intervention: Testicular cancer patients (TCPs)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 38
Study: 32065508

Group type: EXPERIMENTAL
Intervention: Simultaneous epiduroscopic laser neural disc decompression (ELND) and percutaneous laser disc decompression (PLDD) using Ho:YAG laser
Number of subjects: 41
Study: 32778008

Group type: EXPERIMENTAL
Intervention: Iron-fortified formula (12.7 mg/L)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Low-iron formula (2.3 mg/L)
Number of subjects: 443
Study: 33034872

Group type: EXPERIMENTAL
Intervention: Breast Self-Examination (BSE) awareness and practice
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Awareness of screening methods for breast cancer
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Awareness of risk factors for breast cancer
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sociodemographic factors influencing BSE practice
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Overall awareness and practice of BSE and screening
Number of subjects: 202
Study: 33251832

Group type: EXPERIMENTAL
Intervention: Nepafenac
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nepafenac-free
Number of subjects: 45
Study: 32654629

Group type: EXPERIMENTAL
Intervention: Excessive total fatty acid intake
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Omega-6/omega-3 ratio above 10:1
Number of subjects: 60
Study: 32028138

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 120
Study: 34047449

Group type: EXPERIMENTAL
Intervention: FiASP-and-pramlintide with SMA
Number of subjects: 7

Group type: COMPARATOR
Intervention: FiASP-and-placebo with FCC
Number of subjects: 7

Group type: COMPARATOR
Intervention: FiASP-and-placebo with SMA
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 7

Group type: COMPARATOR
Intervention: FiASP-and-placebo with FCC and SMA interventions
Number of subjects: 7
Study: 33252896

Group type: EXPERIMENTAL
Intervention: Resourcefulness Training + Routine Health Education
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine Health Education
Number of subjects: 72
Study: 34304121

Group type: EXPERIMENTAL
Intervention: Cocaine RCTs
Number of subjects: 1689

Group type: COMPARATOR
Intervention: Methamphetamine RCTs
Number of subjects: 1689
Study: 32479329

Group type: EXPERIMENTAL
Intervention: Combined physical activity in the previous hour
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity in the previous hour
Number of subjects: 43
Study: 35654226

Group type: EXPERIMENTAL
Intervention: cEEG (30-48 hours)
Number of subjects: 112

Group type: COMPARATOR
Intervention: rEEG (two sessions of 20-30 minutes each)
Number of subjects: 112
Study: 34174564

Group type: EXPERIMENTAL
Intervention: Dietary tryptophan levels of 1.00, 2.00, 3.00, 4.00, 5.00, and 6.00 g/kg
Number of subjects: 504
Study: 32869396

Group type: EXPERIMENTAL
Intervention: Brighton Collaboration GBS case definitions applied to retrospective cohort
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brighton Collaboration GBS case definitions applied to prospective cohort
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSF investigations conducted in all patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nerve conduction studies performed in cohorts
Number of subjects: 0
Study: 35670155

Group type: EXPERIMENTAL
Intervention: MCC-CG (Managing Cancer Care: A Caregiver's Guide)
Number of subjects: 35
Study: 34303444

Group type: EXPERIMENTAL
Intervention: Teachers' self-efficacy beliefs, relationship experiences, and externalizing symptom ratings
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Teachers' experience level
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Children's levels of closeness
Number of subjects: 690
Study: 34267120

Group type: EXPERIMENTAL
Intervention: Magic Saws
Number of subjects: 258

Group type: COMPARATOR
Intervention: Conventional Osteotomes
Number of subjects: 258
Study: 33676589

Group type: EXPERIMENTAL
Intervention: Tocilizumab 6 mg/kg plus standard care
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 180
Study: 32180507

Group type: EXPERIMENTAL
Intervention: Kripalu Yoga in the Schools (KYIS) intervention integrated into physical education class (n = 9)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Art and music (control condition; n = 14)
Number of subjects: 23
Study: 33564844

Group type: COMPARATOR
Intervention: Heavy resistance training 3 times weekly with whey protein supplementation (HRTW)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Light-intensity resistance training 3-5 times/wk with whey protein supplementation (LITW)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Collagen protein supplementation (COLL)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Whey protein supplementation (WHEY)
Number of subjects: 208
Study: 32401967

Group type: EXPERIMENTAL
Intervention: Hydrophobic acrylic square‐edged IOLs
Number of subjects: 26

Group type: COMPARATOR
Intervention: Hydrophilic acrylic square‐edged IOLs
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 35762773

Group type: EXPERIMENTAL
Intervention: Pain-free exercise (PF)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Moderate pain exercise (MOD-P)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Maximal pain exercise (MAX-P)
Number of subjects: 51
Study: 33395498

Group type: EXPERIMENTAL
Intervention: Twice-weekly Structured Interdisciplinary Bedside Rounds (SIBR)
Number of subjects: 3673
Study: 32036824

Group type: EXPERIMENTAL
Intervention: VAC dressing after split thickness skin graft
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple dressing after split thickness skin graft
Number of subjects: 120
Study: 35973183

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acustimulation (TEA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham-TEA
Number of subjects: 52
Study: 34470322

Group type: EXPERIMENTAL
Intervention: Structured Porous Coated Cylinders (SPCCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (bare cylinder)
Number of subjects: 0
Study: 35795897

Group type: EXPERIMENTAL
Intervention: 12-week health education program applying social marketing and Health Belief Model (HBM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual services (comparison group)
Number of subjects: 150
Study: 34728206

Group type: EXPERIMENTAL
Intervention: CO2 monitors intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham (placebo) control
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 12
Study: 32620866

Group type: EXPERIMENTAL
Intervention: Spa-rehab therapy
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard spa therapy
Number of subjects: 283
Study: 36114653

Group type: EXPERIMENTAL
Intervention: Ketone monoester (27 g per dose, thrice daily for 3 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isocaloric maltodextrin placebo (PLA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ketone monoester (KES)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both KES and PLA
Number of subjects: 16
Study: 34390228

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study: 35330843

Group type: EXPERIMENTAL
Intervention: Abacus mental calculation training (AMC); specific dosage and duration not mentioned.
Number of subjects: 28
Study: 35775225

Group type: EXPERIMENTAL
Intervention: Exercise intervention (circuit-based aerobic and resistance exercise, 65-85% of VO2max and 65-85% of 1-repetition maximum, 3 times per week for 16 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 90
Study: 33831271

Group type: EXPERIMENTAL
Intervention: Heliox (n=35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Air-oxygen mixed gas (Control group, n=36)
Number of subjects: 71
Study: 32410379

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration using autogenous bone/deproteinized bovine bone mineral grafting mixture and collagen membrane
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration
Number of subjects: 15
Study: 36513442

Group type: EXPERIMENTAL
Intervention: Moderate daily consumption of cachaça (28 g ethanol/day for men, 14 g for women)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Moderate daily consumption of red wine (28 g ethanol/day for men, 14 g for women)
Number of subjects: 40
Study: 33797681

Group type: EXPERIMENTAL
Intervention: Intention (OR=1.49, 95% CI=1.21-1.84, p=0.001)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Subjective norm (OR=1.57, 95% CI=1.15-2.13, p=0.004)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Perceived behavioural control (OR=1.53, 95% CI=1.21-1.92, p=0.001)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Perceived severity (OR=1.57, 95% CI=1.15-2.16, p=0.005)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Perceived barriers (OR=0.52, 95% CI=0.39-0.67, p=0.001)
Number of subjects: 633
Study: 32224129

Group type: EXPERIMENTAL
Intervention: Tight control strategy (increased therapy based on fecal calprotectin, serum C-reactive protein, and symptoms)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Deep remission (CD endoscopic index of severity scores below 4, no deep ulcerations or steroid treatment for 8 or more weeks)
Number of subjects: 122
Study: 33969511

Group type: EXPERIMENTAL
Intervention: Medication reconciliation model led by a hospital clinical pharmacist
Number of subjects: 353
Study: 32554766

Group type: EXPERIMENTAL
Intervention: Goals-of-care decision aid
Number of subjects: 18
Study: 34964311

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day plus rifaximin 1,200 mg/day for 3 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 36057024

Group type: EXPERIMENTAL
Intervention: ADAPT intervention (After Deployment Adaptive Parenting Tools)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 185
Study: 34398242

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy (CPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32366866

Group type: EXPERIMENTAL
Intervention: 30-minute slow breathing exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Music listening (Max Richter: Sleep)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 20
Study: 35451230

Group type: EXPERIMENTAL
Intervention: Clemizole (1 mM, bath application)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone (1 mM, bath application)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valproate (VPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethosuximide (ESX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levetiracetam (LEV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam (DZP)
Number of subjects: 0
Study: 34146594

Group type: EXPERIMENTAL
Intervention: 4-g Alkyrol® (purified shark liver oil) per day for 3 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (methylcellulose)
Number of subjects: 10
Study: 34388256

Group type: EXPERIMENTAL
Intervention: Overexpansion group (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional expansion group (n = 12)
Number of subjects: 23
Study: 33186715

Group type: EXPERIMENTAL
Intervention: Sleep deprivation (32 hours)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Normal sleep-wake cycle (SWC)
Number of subjects: 46
Study: 32919170

Group type: EXPERIMENTAL
Intervention: Moulage simulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Pressure ulcer visuals simulation (Control)
Number of subjects: 73
Study: 35940529

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 50 mg/kg daily from 9 days before HSCT to 30 days after HSCT
Number of subjects: 160
Study: 33832645

Group type: EXPERIMENTAL
Intervention: Meclon Idra vaginal gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35272801

Group type: EXPERIMENTAL
Intervention: iFR
Number of subjects: 2037

Group type: COMPARATOR
Intervention: FFR
Number of subjects: 2037
Study: 32498639

Group type: EXPERIMENTAL
Intervention: Children with learning difficulties (LD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Children without learning difficulties (LD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: FPlinR, DDR, and ANMF scores
Number of subjects: 50
Study: 35190840

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 2410

Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 2410

Group type: EXPERIMENTAL
Intervention: Dobutamine use
Number of subjects: 2410

Group type: EXPERIMENTAL
Intervention: SAPS II score ≥ 62
Number of subjects: 2410

Group type: EXPERIMENTAL
Intervention: Hemoglobin concentration ≤ 10.9 g/dL
Number of subjects: 2410
Study: 33635894

Group type: EXPERIMENTAL
Intervention: Cervical transcutaneous vagal nerve stimulation for two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment for two weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical transcutaneous vagal nerve stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study: 32734919

Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT); 9 sessions, 2 hours each, once weekly (n = 35)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Computerized Cognitive Training (CCT); 9 sessions, 1 hour each, twice weekly (n = 28)
Number of subjects: 63
Study: 34764044

Group type: EXPERIMENTAL
Intervention: Tocilizumab-hydroxychloroquine (TCZ-HCQ)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Tocilizumab-remdesivir (TCZ-RMV)
Number of subjects: 108
Study: 33798217

Group type: EXPERIMENTAL
Intervention: Structured cardiac ultrasound education and rotation program
Number of subjects: 23
Study: 33433153

Group type: EXPERIMENTAL
Intervention: Exercise intervention (high-intensity interval training on a cycloergometer thrice a week for 4 months per year)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 32745244

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion adjusted by a standard algorithm
Number of subjects: 94
Study: 35266971

Group type: EXPERIMENTAL
Intervention: Participants who screened positive for depression
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Lower MCS score (worse depression)
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Inflammatory markers (cytokines in tears and HLA-DR expression)
Number of subjects: 535
Study: 33290442

Group type: EXPERIMENTAL
Intervention: Jaw exercises
Number of subjects: 97

Group type: COMPARATOR
Intervention: Stabilization appliance
Number of subjects: 97

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 97
Study: 35851976

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health promotion condition
Number of subjects: 192
Study: 33938946

Group type: EXPERIMENTAL
Intervention: Internet-based intervention (standardized online learning for teachers with minimal in-person support, duration 9-10 months)
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Control intervention (not specified)
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: Internet-based intervention
Number of subjects: 1188
Study: 32014046

Group type: EXPERIMENTAL
Intervention: Financial incentives in addition to interactive management of mobile devices, conditional on achieving antihypertensive goals.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Interactive management of mobile devices, including patient education and communication.
Number of subjects: 400